TNF Pharmaceuticals (TNFA) Competitors $0.10 0.00 (-1.63%) Closing price 04:00 PM EasternExtended Trading$0.10 0.00 (-0.52%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. PRTG, JBIO, HCWB, LIAN, GTBP, VYNE, THAR, PPBT, SLXN, and BCTXShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Portage Biotech (PRTG), Jade Biosciences (JBIO), HCW Biologics (HCWB), LianBio (LIAN), GT Biopharma (GTBP), VYNE Therapeutics (VYNE), Tharimmune (THAR), Purple Biotech (PPBT), Silexion Therapeutics (SLXN), and Briacell Therap (BCTX). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors Portage Biotech Jade Biosciences HCW Biologics LianBio GT Biopharma VYNE Therapeutics Tharimmune Purple Biotech Silexion Therapeutics Briacell Therap TNF Pharmaceuticals (NASDAQ:TNFA) and Portage Biotech (NASDAQ:PRTG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Which has more volatility & risk, TNFA or PRTG? TNF Pharmaceuticals has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500. Does the media favor TNFA or PRTG? In the previous week, TNF Pharmaceuticals' average media sentiment score of 0.00 equaled Portage Biotech'saverage media sentiment score. Company Overall Sentiment TNF Pharmaceuticals Neutral Portage Biotech Neutral Do insiders & institutionals have more ownership in TNFA or PRTG? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 13.4% of Portage Biotech shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by company insiders. Comparatively, 42.1% of Portage Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is TNFA or PRTG more profitable? Portage Biotech's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -97.38% -37.37% Portage Biotech N/A N/A N/A Which has higher valuation & earnings, TNFA or PRTG? Portage Biotech is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$23.36M-$6.67-0.01Portage BiotechN/AN/A-$6.77M-$41.65-0.22 SummaryPortage Biotech beats TNF Pharmaceuticals on 5 of the 8 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.40M$2.42B$5.44B$9.61BDividend YieldN/A1.80%4.61%4.14%P/E Ratio-0.0120.5929.7524.84Price / SalesN/A698.88449.4898.68Price / CashN/A171.7436.4258.36Price / Book0.034.328.185.64Net Income-$23.36M$31.61M$3.26B$265.68M7 Day PerformanceN/A0.46%1.15%2.51%1 Month PerformanceN/A2.42%2.82%1.88%1 Year PerformanceN/A4.44%28.41%24.00% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.10-1.6%N/AN/A$1.40MN/A-0.016PRTGPortage Biotech0.3347 of 5 stars$5.85+7.9%N/A+209.8%$6.14MN/A-0.146JBIOJade Biosciences1.5781 of 5 stars$7.29+5.8%$15.00+105.8%N/A$6.13MN/A-0.1220HCWBHCW Biologics2.8473 of 5 stars$4.22+2.1%$35.00+730.4%-81.2%$6.12M$1.45M-0.1840Upcoming EarningsLIANLianBioN/A$0.05flatN/A-82.3%$5.87MN/A-0.07110GTBPGT Biopharma1.9973 of 5 stars$1.76-2.8%$11.00+525.0%-18.7%$5.77MN/A-0.318Upcoming EarningsVYNEVYNE Therapeutics2.5385 of 5 stars$0.38+3.0%$6.25+1,562.2%-77.8%$5.70M$500K-0.3830Upcoming EarningsGap UpTHARTharimmune3.3062 of 5 stars$1.35+8.9%$17.00+1,159.3%-53.0%$5.70MN/A-0.172Gap DownPPBTPurple Biotech2.449 of 5 stars$2.17-2.0%$33.00+1,424.2%N/A$5.61MN/A-0.8320News CoverageEarnings ReportUpcoming EarningsSLXNSilexion TherapeuticsN/A$8.93-1.3%$75.00+740.3%N/A$5.18MN/A0.00N/ABCTXBriacell Therap1.6245 of 5 stars$0.76+1.1%$32.00+4,094.0%-92.4%$5.17MN/A-0.098Stock Split Related Companies and Tools Related Companies Portage Biotech Alternatives Jade Biosciences Alternatives HCW Biologics Alternatives LianBio Alternatives GT Biopharma Alternatives VYNE Therapeutics Alternatives Tharimmune Alternatives Purple Biotech Alternatives Silexion Therapeutics Alternatives Briacell Therap Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNFA Stock Alerts